New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
14:01 EDTACORAcorda Therapeutics sees FY13 AMPYRA U.S. net sales $285M-$315M
Sees other revenue of $25M (FAMPYRA and Zanaflex), which includes $9.1M in amortized license revenue. Comment from slides that will be presented at the 31st Annual JP Morgan Healthcare Conference.
News For ACOR From The Last 14 Days
Check below for free stories on ACOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use